1Kempf RA,Mitchell MS. Effects of chemotherapeutic agents on the immune response.I[J] . Cancer Invest,1984,2(6) :459-466.
2Lutsiak ME,Semnani RT,De Pascalis R,et al.Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide[J] . Blood,2005,105(7) :2862-2868.
3van der Most RG,Currie A,Robinson BW,et al. Cranking the immunologic engine with chemotherapy:using context to drive tumor antigen cross-presentation towards useful anti-tumor immunity[J] . Cancer Res,2006,66(2) :601-604.
4Strender LE,Blomgren H,Petrini B,et al. Immunologic monitoring in breast cancer patients receiving postoperative adjuvant chemotherapy[J] . Cancer,1981,48(9) :1996-2002.
5Nichols PH,Ward U,Ramsden CW,et al. The effect of 5-fluorouracil and alpha interferon and 5-fluorouracil and leucovorin on cellular anti-tumor immune responses in patients with advanced colorectal cancer[J] . Br J Cancer,1994,70(5) :946-949.
6Hamann D,Baars PA,Rep MH,et al. Phenotypic and functional separation of memory and effector human CD8+ T cells[J] . J Exp Med,1997,186(9) :1407-1418.
7Sallusto F,Lenig D,Forster R,et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions[J] . Nature,1999,401(6754) :708-712.
8Rufer N,Zippelius A,Batard P,et al. Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions[J] . Blood,2003,102(5) :1779-1787.
9Matsui M,Araya S,Wang HY,et al. Circulating lymphocyte subsets linked to intracellular cytokine profiles in normal humans[J] . Clin Exp Immunol,2003,134(2) :225-231.
10Diagbouga S,Chiron JP,Sanou O,et al. Alteration in CD29(high) CD4(+) lymphocyte subset is a common feature of early HIV disease and of active tuberculosis[J] . Scand J Immunol,2001,53(1) :79-84.
